Caspase-8 is required for extrinsic apoptosis, but is also central for preventing a pro-inflammatory receptor interacting protein kinase (RIPK) 3-mixed lineage kinase domain-like (MLKL)-dependent cell death pathway termed necroptosis. Despite these critical cellular functions, the impact of capase-8 deletion in the myeloid cell lineage, which forms the basis for innate immune responses, has remained unclear. In a recent article in Arthritis Research & Therapy, Cuda et al. report that myeloid cell-restricted caspase-8 loss leads to a very mild RIPK3-dependent inflammatory phenotype. The presented results suggest that inflammation does not arise exclusively because of RIPK3-mediated necroptotic death but that, in the absence of caspase-8, RIPK1 and RIPK3 enhance microbiome-driven Toll-like receptor-induced pro-inflammatory cytokine production.
necrosis factor receptor 1 (TNFR1) recruit the adaptor protein Fas-associated death domain (FADD) that serves as a docking platform for pro-caspase-8 molecules and enables caspase-8 dimerization and transactivation. Active caspase-8 subsequently initiates apoptosis via proteolytic activation of downstream effector caspases. Caspase-8 activation has therefore been suggested as a promising approach for developing new anti-cancer therapies [3] . On the other hand, caspase-8 mutation causes lymphoproliferative disorder and immunodeficiency in people, and reduced caspase-8 expression is associated with atopic dermatitis and epidermal wound responses [4] .
Recent mouse studies have uncovered additional roles for caspase-8 in regulating cell death and inflammatory responses, which may help explain its capacity to either induce or limit inflammation under specific conditions (Fig. 1) . In some circumstances, TLR or death receptors can activate pro-inflammatory interleukin (IL)-1β, either via direct caspase-8-mediated proteolytic cleavage [5] or by caspase-8 activation of the Nod-like receptor 3 (NLRP3)-caspase-1 inflammasome [6] . Moreover, caspase-8 also acts in a pro-survival capacity, because its catalytic activity is essential for suppressing TLR and death receptor-mediated necroptotic killing [7] . When caspase-8 function is compromised, TLRs or TNFR1 signal through the receptor interacting protein kinase RIPK1 to induce the oligomerization and kinase activity of RIPK3. Subsequently, RIPK3 phosphorylates mixed lineage kinase domain-like (MLKL), and MLKL then inserts into cellular membranes, including the plasma membrane, to disrupt their integrity. Unlike apoptotic cell death, necroptosis-induced cellular rupture is thought to trigger inflammation through the release of intracellular danger molecules, termed damageassociated molecular patterns (DAMPs). Consistent with this, genetic inactivation of caspase-8 can signal necroptosis to cause inflammation, and necroptotic killing has been linked to a variety of diseases, including atherosclerosis and renal ischaemic reperfusion injury [7] .
Macrophage survival during differentiation was previously reported to require caspase-8 expression [8] , consistent with its role in keeping RIPK3-induced necroptosis signalling in check. However, Cuda et al. [1] now report relatively efficient caspase-8 deletion in neutrophils, monocytes and macrophages (Casp8 fl/fl LysMCre ). These mice developed mild systemic inflammation, presenting with splenomegaly and lymphadenopathy, increased splenic monocytes/macrophages, and a slight serological elevation in a subset of cytokines and chemokines. Strikingly, antibiotic treatment rescued the splenomegaly and lymphadenopathy in Casp8 fl/fl LysMCre mice, implying that intestinal microflora trigger the abnormal immune responses following myeloid cell-specific caspase-8 loss. Similarly, co-deletion of RIPK3 in Casp8 fl/fl LysMCre mice restored all inflammatory markers to normal. This implies that caspase-8 deletion alone is insufficient to trigger spontaneous RIPK3 signalling, but that upon microbedependent TLR engagement, caspase-8 blunts aberrant RIPK3 activity.
The tissue or cell-type specific deletion of caspase-8 has frequently been observed to induce a strong proinflammatory phenotype that is rescued by RIPK3 codeletion [7] . Although DAMP release from dying cells is presumed to be the major inflammatory trigger, activated RIPK1/3 may also promote transcriptional cytokine responses [9, 10] . Consistent with the latter, Cuda et al. observed that resting, M1 polarized or TLRstimulated caspase-8-deficient macrophages displayed a distinct transcriptional profile, which was restored upon RIPK1 inhibition. These data imply that cell-intrinsic RIPK1/3-mediated gene induction contributes to the phenotype of Casp8 fl/fl LysMCre mice, independent of necroptotic DAMP release.
Caspase-8 deletion in dendritic cells (DCs) sensitizes mice to lipopolysaccharide (LPS)-induced lethality resulting from excess RIPK3-driven NLRP3 inflammasome activation and IL-1β production [11] . Similarly, caspase-8 deletion in the skin or gut triggers severe inflammation that is dependent on RIPK3 [12] . Somewhat contrary to expectations, Cuda et al. demonstrate that the injection of LPS into Casp8 fl/fl LysMCre mice results in reduced cytokine production compared with wild-type controls. This infers that caspase-8 may be required for optimal TLR-induced cytokine transcriptional responses, as observed previously in LPS-treated caspase-8 and RIPK3 doubly-deficient mice and macrophages [13] . The reduced cytokine production also suggests that LPStriggered IL-1β activation could depend on caspase-8 activation of NLRP3-caspase-1, or on direct caspase-8 proteolysis of precursor IL-1β. Alternatively, it is also possible that LPS-induced necroptosis of caspase-8-deficient myeloid cells in vivo may blunt their capacity for producing inflammatory cytokines.
In summary, the research by Cuda et al. expands our knowledge of the multifaceted roles of caspase-8 in regulating immune responses. Although results point towards increased RIPK3 signalling causing aberrant TLR responses following caspase-8 loss in myeloid cells, it remains unclear how much of the in vivo phenotype is driven by necroptosis versus RIPK3-induced inflammatory cytokine production. In this regard, the co-deletion of the requisite downstream necroptotic protein MLKL in caspase-8-deficient myeloid cells may be particularly informative, because this would leave much of the RIPK1/3 inflammatory signalling capacity intact. Notably, the phenotype observed in myeloid cell-deficient caspase-8 mice contrasts with results observed upon caspase-8 deletion in DCs, which induces a more pronounced autoimmune phenotype that is not fully RIPK3 dependent [11, 14] . This serves to highlight immune celltype specific roles for caspase-8 that are critical for shaping both innate and adaptive immune responses. 
